# PBPH holdings: all 53 positions

> All 53 PBPH holdings with weights, as of Jul 31, 2026. The top 3 are LLY 15.20%, JNJ 9.66% and ABBV 6.94%. Download the full list as a CSV.

Data as of Jul 31, 2026. Rebuilt every trading night.

PBPH held 53 positions as of Jul 31, 2026. Eli Lilly & Co is the largest at 15.20%; the top 10 are 61.9% of the fund.

Source: Form N-PORT filed with the SEC (https://www.sec.gov/Archives/edgar/data/2043390/000200032426004430/primary_doc.xml).

| # | Holding | Ticker | Weight |
| --- | --- | --- | --- |
| 1 | Eli Lilly & Co | LLY | 15.20% |
| 2 | Johnson & Johnson | JNJ | 9.66% |
| 3 | AbbVie Inc | ABBV | 6.94% |
| 4 | Merck & Co Inc | MRK | 5.04% |
| 5 | Roche Holding AG | ROP | 4.74% |
| 6 | Amgen Inc | AMGN | 4.63% |
| 7 | Novartis AG | NOVN | 4.47% |
| 8 | Astrazeneca PLC | AZN | 3.90% |
| 9 | Gilead Sciences Inc | GILD | 3.77% |
| 10 | Novo Nordisk A/S | NOVOB | 3.51% |
| 11 | Pfizer Inc | PFE | 3.33% |
| 12 | Bristol-Myers Squibb Co | BMY | 3.11% |
| 13 | Vertex Pharmaceuticals Inc | VRTX | 2.82% |
| 14 | GSK PLC | GSK | 2.26% |
| 15 | Sanofi SA | SAN | 2.17% |
| 16 | Regeneron Pharmaceuticals Inc | REGN | 1.79% |
| 17 | Bayer AG | BAYN | 1.27% |
| 18 | Takeda Pharmaceutical Company Ltd | 4502 | 1.25% |
| 19 | Argenx SE | ARGX | 1.24% |
| 20 | CSL Ltd | CSL | 1.11% |
| 21 | Teva Pharmaceutical Industries Ltd | TEVA | 0.96% |
| 22 | Natera Inc | NTRA | 0.85% |
| 23 | Sandoz Group AG | SDZ | 0.78% |
| 24 | Revolution Medicines Inc | RVMD | 0.77% |
| 25 | Zoetis Inc | ZTS | 0.76% |
| | Cash and other net assets | | 0.55% |

The largest 25 of 53 positions are shown. All of them: https://etfiq.com/funds/pbph/holdings/pbph-holdings.csv (CSV) or https://etfiq.com/data/books/pbph.json (JSON).

Fund page: https://etfiq.com/funds/pbph

Cite: ETFIQ, Holdings of PBPH, data as of Jul 31, 2026. https://etfiq.com/funds/pbph/holdings/